HTA229 PICO Criteria Applied in Joint Action 3 Differ From National HTA Requirements: A Review of Oncology Drug Assessments in Denmark, France, Germany, and Sweden
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1912
https://www.valueinhealthjournal.com/article/S1098-3015(23)05042-8/fulltext
Section Title :
Section Order :
11353
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05042-8&doi=10.1016/j.jval.2023.09.1912